Expertise in
5
conditions

Dr. Susan Mcelroy

Psychiatry
Office
4075 Old Western Row Rd # C, 
Mason, OH 
Expertise in
5
conditions
Office
4075 Old Western Row Rd # C, 
Mason, OH 

Overview

Susan Mcelroy is a Psychiatrist in Mason, Ohio. Dr. Mcelroy is highly rated in 5 conditions, according to our data. Her top areas of expertise are Bipolar Disorder (BPD), Bulimia, Anorexia, and Major Depression.

Her clinical research consists of co-authoring 302 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in OH

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
4075 Old Western Row Rd # C, Mason, OH 45040

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An 8 Week Randomized Double Blind Placebo Controlled Multi-site Study Assessing Efficacy and Safety of MYDAYIS® (D-amphetamine / L-amphetamine) for Bipolar Depression
An 8 Week Randomized Double Blind Placebo Controlled Multi-site Study Assessing Efficacy and Safety of MYDAYIS® (D-amphetamine / L-amphetamine) for Bipolar Depression
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Drug
Study Drug: MYDAYIS
Study Phase: Phase 2
A Randomized, Placebo-Controlled Study of Liraglutide 3mg Daily (Saxenda®) in Obese or Overweight Patients With Stable Bipolar Disorder
A Randomized, Placebo-Controlled Study of Liraglutide 3mg Daily (Saxenda®) in Obese or Overweight Patients With Stable Bipolar Disorder
Enrollment Status: Completed
Publish Date: March 12, 2025
Intervention Type: Drug, Other
Study Drug: Liraglutide
Study Phase: Phase 2
The SPD489-344, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
The SPD489-344, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
Enrollment Status: Completed
Publish Date: July 16, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Forced-dose Titration Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Binge Eating Disorder
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Forced-dose Titration Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Binge Eating Disorder
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 3
The SPD489-343, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
The SPD489-343, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Validation Study to Measure the Impact of a Proteomic Assay in Distinguishing Bipolar I Disorder, Bipolar II Disorder, and Major Depressive Disorder in People Presenting With a Major Depressive Episode
A Validation Study to Measure the Impact of a Proteomic Assay in Distinguishing Bipolar I Disorder, Bipolar II Disorder, and Major Depressive Disorder in People Presenting With a Major Depressive Episode
Enrollment Status: Completed
Publish Date: May 14, 2020
Intervention Type: Other
View 6 Less Clinical Trials

302 Total Publications

Author Correction: Fine-mapping genomic loci refines bipolar disorder risk genes.
Author Correction: Fine-mapping genomic loci refines bipolar disorder risk genes.
Journal: Nature neuroscience
Published: October 28, 2025
Similar Doctors
Expertise in
12
conditions
Dr. James Shackson
Psychiatry
Expertise in
12
conditions
Dr. James Shackson
Psychiatry

Brookwood Retirement Community

12100 Reed Hartman Hwy, 
Cincinnati, OH 
 (5.1 miles away)
513-382-5112
Languages Spoken:
English
See accepted insurances

James Shackson is a Psychiatrist in Cincinnati, Ohio. Dr. Shackson is highly rated in 12 conditions, according to our data. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Generalized Anxiety Disorder (GAD), and Schizophrenia.

Expertise in
1
conditions
Dr. Stephen Strakowski
Psychiatry
Expertise in
1
conditions
Dr. Stephen Strakowski
Psychiatry

University Psychiatric Associates LLC

260 Stetson St Ste 3200, 
Cincinnati, OH 
 (18.6 miles away)
513-558-4274
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Strakowski is a Psychiatrist in Cincinnati, Ohio. Dr. Strakowski is highly rated in 1 condition, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Generalized Anxiety Disorder (GAD), Major Depression, and Schizophrenia.

Expertise in
10
conditions
Dr. Nelson Rodriguez
Psychiatry
Expertise in
10
conditions
Dr. Nelson Rodriguez
Psychiatry

Lindner Center Of Hope

4075 Old Western Row Rd, 
Mason, OH 
 (0.1 miles away)
513-536-4633
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nelson Rodriguez is a Psychiatrist in Mason, Ohio. Dr. Rodriguez is highly rated in 10 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), Major Depression, and Schizoaffective Disorder.

Frequently Asked Questions about Dr. Susan Mcelroy

How do I make an appointment with Dr. Susan Mcelroy?

You can book an appointment with Dr. Susan Mcelroy by calling their office at 513-536-4673. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Susan Mcelroy a top-rated expert for Bipolar Disorder (BPD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Susan Mcelroy is classified as an Elite expert for Bipolar Disorder (BPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Susan Mcelroy specialize in?

While Dr. Susan Mcelroy is a Psychiatry, they have specific expertise in Bipolar Disorder (BPD), Bulimia, and Anorexia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Susan Mcelroy participate in research or clinical trials?

Yes. Dr. Susan Mcelroy has published 302 articles and abstracts on conditions like Bipolar Disorder (BPD). You can view a list of Dr. Susan Mcelroy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Susan Mcelroy accept my insurance?

Dr. Susan Mcelroy accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 513-536-4673 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mcelroy's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile